News
Summary of Hematology and Pathology Devices Panel Meeting
A summary of speeches and events. Read more
IVD Roundtable at the FDA, Jan. 13, 2010
At the FDA, the OBRR Director Jay Epstein welcomed us and introduced the first speaker, Sayah Nedjar, who gave us a CBER update. Read more
Marketing drugs or devices to health care providers? The national legal trend is “no more tchotchkes”.
As of today, seven states and the District of Columbia have enacted laws addressing marketing practices of pharmaceutical manufacturers, in terms of gifts and perks provided to their customers. Read more
